secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001140361-25-021612
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Gyre Therapeutics reports shareholder meeting results; all proposals approved
-----------------------------------------------------------------------------

- Gordon Carmichael, Ph.D., elected as Class I director with 69,249,334 votes for, 297,881 withheld.
- Songjiang Ma elected with 69,385,506 votes for, 161,709 withheld; Ping Zhang with 69,320,687 for, 226,528 withheld.
- Non-binding advisory vote on executive compensation approved: 69,505,961 for, 39,318 against, 1,936 abstained.
- Ratification of Grant Thornton Zhitong as independent auditor for FY2025 approved: 72,175,754 for, 3,738 against, 146,263 abstained.
- Total shares entitled to vote: 93,742,602; broker non-votes reported for director elections and compensation vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000114036125021612/0001140361-25-021612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000114036125021612/ef20050192_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-021612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer